Listed

Sunshine Biopharma Inc.

SBFMNasdaqCIK 1402328HealthcareFiscal year ends Dec 31

Reports and events: 194 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Sunshine Biopharma Inc., Reports and events
FiledFormWhat it isAccession number
2022-02-0317:31 ETS-1/ARegistration statement, amended0001683168-22-000663
2022-01-2416:24 ETS-1/ARegistration statement, amended0001683168-22-000418
2021-12-2208:01 ET8-K3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001683168-21-006502
2021-11-0916:50 ET10-QQuarterly reportPeriod 2021-09-300001683168-21-005363
2021-11-0312:36 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001683168-21-005210
2021-09-0920:52 ETS-1Registration statement0001683168-21-004175
2021-08-0912:01 ET10-QQuarterly reportPeriod 2021-06-300001683168-21-003345
2021-05-1116:26 ET10-QQuarterly reportPeriod 2021-03-310001654954-21-005450
2021-03-3015:24 ET10-KAnnual reportPeriod 2020-12-310001654954-21-003507
2020-11-1221:02 ET10-QQuarterly reportPeriod 2020-09-300001654954-20-012128
2020-10-1908:01 ET8-K1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001654954-20-011251
2020-09-1508:36 ET8-K1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001654954-20-010083
2020-08-3117:42 ET10-Q/AQuarterly report, amendedPeriod 2020-06-300001654954-20-009628
2020-08-1913:19 ET10-QQuarterly reportPeriod 2020-06-300001654954-20-009340
2020-06-2413:07 ET8-K3.02 Unregistered sale of equity; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits0001654954-20-006915
2020-06-0309:03 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001654954-20-006273
2020-05-1815:35 ET10-QQuarterly reportPeriod 2020-03-310001654954-20-005714
2020-05-0118:59 ET10-KAnnual reportPeriod 2019-12-310001654954-20-004731
2020-04-1311:16 ET8-K8.01 Other events0001654954-20-003982
2019-11-1314:54 ET10-QQuarterly reportPeriod 2019-09-300001654954-19-012832
2019-08-1513:29 ET10-QQuarterly reportPeriod 2019-06-300001654954-19-009672
2019-07-1916:04 ET8-K1.02 Termination of a material agreement; 9.01 Financial statements and exhibits0001654954-19-008360
2019-05-2013:06 ET10-QQuarterly reportPeriod 2019-03-310001654954-19-006301
2019-04-1217:08 ET10-KAnnual reportPeriod 2018-12-310001654954-19-004354
2019-03-1208:38 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001654954-19-002574
2018-11-1616:59 ET10-QQuarterly reportPeriod 2018-09-300001654954-18-012900
2018-10-0916:09 ETS-1Registration statement0001654954-18-010915
2018-09-1413:15 ET8-K1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001654954-18-010186
2018-08-1709:01 ET10-QQuarterly reportPeriod 2018-06-300001654954-18-009279
2018-05-2217:56 ET10-QQuarterly reportPeriod 2018-03-310001654954-18-005724
2018-04-0215:51 ET10-KAnnual reportPeriod 2017-12-310001654954-18-003495
2018-01-0412:44 ET8-K1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001654954-18-000098
2017-11-1510:21 ET10-QQuarterly reportPeriod 2017-09-300001654954-17-010704
2017-09-0516:20 ET8-K1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001654954-17-008137
2017-08-1116:09 ET10-QQuarterly reportPeriod 2017-06-300001654954-17-007370
2017-06-2312:29 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001654954-17-005826
2017-05-1215:40 ET10-QQuarterly reportPeriod 2017-03-310001654954-17-004568
2017-04-1714:24 ET10-KAnnual reportPeriod 2016-12-310001654954-17-003365
2016-11-1415:02 ET10-QQuarterly reportPeriod 2016-09-300001654954-16-003935
2016-08-1614:13 ET10-QQuarterly reportPeriod 2016-06-300001654954-16-001658
2016-08-0912:14 ET8-K/A3.02 Unregistered sale of equity0001654954-16-001290
2016-08-0113:13 ET8-K3.02 Unregistered sale of equity0001654954-16-001078
2016-05-0916:09 ET10-QQuarterly reportPeriod 2016-03-310001354488-16-007274
2016-03-2515:57 ET10-KAnnual reportPeriod 2015-12-310001354488-16-006700
2016-03-1414:57 ET8-K1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001654954-16-000160
2015-12-2814:11 ET8-K1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001354488-15-005669
2015-11-0414:41 ET10-QQuarterly reportPeriod 2015-09-300001354488-15-004810
2015-10-0912:54 ET8-K1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001354488-15-004592
2015-08-0616:04 ET10-QQuarterly reportPeriod 2015-06-300001354488-15-003598
2015-08-0411:05 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001354488-15-003541

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 14, 2026, 19:46 ET. Listed shows no prices and gives no investment advice.